

QuidelOrtho (QDEL) stock hits 52-week low as Q1 revenue of $615M-$620M misses targets. China snags and a weak flu season drive 32% decline.
You can purchase shares of QuidelOrtho (NASDAQ:QDEL) through any online brokerage.
Other companies in QuidelOrtho’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
QuidelOrtho has a consensus price target of $37.31.
The stock price for QuidelOrtho (NASDAQ: QDEL) is $13.73 last updated October 23, 2026 at 4:00 PM EDT.
There are no upcoming dividends for QuidelOrtho.
QuidelOrtho does not have any upcoming earnings scheduled.
There is no upcoming split for QuidelOrtho.
QuidelOrtho is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and...